288 related articles for article (PubMed ID: 12734814)
1. Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers.
Konno T; Watanabe J; Ishihara K
J Biomed Mater Res A; 2003 May; 65(2):209-14. PubMed ID: 12734814
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxel.
Wada M; Jinno H; Ueda M; Ikeda T; Kitajima M; Konno T; Watanabe J; Ishihara K
Anticancer Res; 2007; 27(3B):1431-5. PubMed ID: 17595758
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of well-defined amphiphilic block copolymers having phospholipid polymer sequences as a novel biocompatible polymer micelle reagent.
Yusa S; Fukuda K; Yamamoto T; Ishihara K; Morishima Y
Biomacromolecules; 2005; 6(2):663-70. PubMed ID: 15762627
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility and drug release behavior of spontaneously formed phospholipid polymer hydrogels.
Kimura M; Takai M; Ishihara K
J Biomed Mater Res A; 2007 Jan; 80(1):45-54. PubMed ID: 16958047
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.
Tamura K; Kikuchi E; Konno T; Ishihara K; Matsumoto K; Miyajima A; Oya M
BMC Cancer; 2015 Apr; 15():317. PubMed ID: 25928041
[TBL] [Abstract][Full Text] [Related]
6. Spontaneously forming hydrogel from water-soluble random- and block-type phospholipid polymers.
Kimura M; Fukumoto K; Watanabe J; Takai M; Ishihara K
Biomaterials; 2005 Dec; 26(34):6853-62. PubMed ID: 15978662
[TBL] [Abstract][Full Text] [Related]
7. Novel immunosuppressant agents targeting activated lymphocytes by biocompatible MPC polymer conjugated with interleukin-2.
Chiba N; Ueda M; Shimada T; Jinno H; Watanabe J; Ishihara K; Kitajima M
Eur Surg Res; 2007; 39(2):103-10. PubMed ID: 17299267
[TBL] [Abstract][Full Text] [Related]
8. Copolymers of 2-methacryloyloxyethyl phosphorylcholine (MPC) as biomaterials.
Nakabayashi N; Iwasaki Y
Biomed Mater Eng; 2004; 14(4):345-54. PubMed ID: 15472384
[TBL] [Abstract][Full Text] [Related]
9. Solubilization of poorly water-soluble compounds using amphiphilic phospholipid polymers with different molecular architectures.
Mu M; Konno T; Inoue Y; Ishihara K
Colloids Surf B Biointerfaces; 2017 Oct; 158():249-256. PubMed ID: 28700969
[TBL] [Abstract][Full Text] [Related]
10. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
11. The characteristics of spontaneously forming physically cross-linked hydrogels composed of two water-soluble phospholipid polymers for oral drug delivery carrier I: hydrogel dissolution and insulin release under neutral pH condition.
Nam K; Watanabe J; Ishihara K
Eur J Pharm Sci; 2004 Nov; 23(3):261-70. PubMed ID: 15489127
[TBL] [Abstract][Full Text] [Related]
12. Water-soluble and amphiphilic phospholipid copolymers having 2-methacryloyloxyethyl phosphorylcholine units for the solubilization of bioactive compounds.
Ishihara K; Mu M; Konno T
J Biomater Sci Polym Ed; 2018; 29(7-9):844-862. PubMed ID: 28891422
[TBL] [Abstract][Full Text] [Related]
13. Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
Shimada T; Ueda M; Jinno H; Chiba N; Wada M; Watanabe J; Ishihara K; Kitagawa Y
Anticancer Res; 2009 Apr; 29(4):1009-14. PubMed ID: 19414339
[TBL] [Abstract][Full Text] [Related]
14. Effects of inner polarity and viscosity of amphiphilic phospholipid polymer aggregates on the solubility enhancement of poorly water-soluble drugs.
Yoshie K; Yada S; Ando S; Ishihara K
Colloids Surf B Biointerfaces; 2020 Nov; 195():111215. PubMed ID: 32652398
[TBL] [Abstract][Full Text] [Related]
15. Selection suitable solvents to prepare paclitaxel-loaded micelles by solvent evaporation method.
Jiao Z; Liu N; Chen Z
Pharm Dev Technol; 2012; 17(2):164-9. PubMed ID: 20977318
[TBL] [Abstract][Full Text] [Related]
16. Translymphatic chemotherapy targeting sentinel lymph nodes using a novel phospholipid polymer-Paclitaxel conjugate.
Oyama T; Takeuchi H; Matsuda S; Ozawa S; Kitajima M; Kitagawa Y
Anticancer Res; 2014 Apr; 34(4):1751-7. PubMed ID: 24692706
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 2-methacryloyloxyethyl phosphorylcholine polymeric nanoparticle for immunoassay of C-reactive protein detection.
Park J; Kurosawa S; Watanabe J; Ishihara K
Anal Chem; 2004 May; 76(9):2649-55. PubMed ID: 15117211
[TBL] [Abstract][Full Text] [Related]
18. Hemocompatibility of human whole blood on polymers with a phospholipid polar group and its mechanism.
Ishihara K; Oshida H; Endo Y; Ueda T; Watanabe A; Nakabayashi N
J Biomed Mater Res; 1992 Dec; 26(12):1543-52. PubMed ID: 1484061
[TBL] [Abstract][Full Text] [Related]
19. Morphology and in vitro release kinetics of drug-loaded micelles based on well-defined PMPC-b-PBMA copolymer.
Chu H; Liu N; Wang X; Jiao Z; Chen Z
Int J Pharm; 2009 Apr; 371(1-2):190-6. PubMed ID: 19162151
[TBL] [Abstract][Full Text] [Related]
20. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
Miyata R; Ueda M; Jinno H; Konno T; Ishihara K; Ando N; Kitagawa Y
Int J Cancer; 2009 May; 124(10):2460-7. PubMed ID: 19173297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
